Որոնման արդյունքները - Randy Strong
- Ցուցադրվում են 1 - 20 արդյունքները 50
- Գնացեք Հաջորդ էջ
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's Disease Margaret Chia-Ying Wey, Elizabeth Fernández, Paul Anthony Martinez, Patricia Sullivan, David S. Goldstein, Randy Strong
Հրապարակվել է 2012Artigo -
11
-
12
-
13
Rapamycin improves motor function, reduces 4-hydroxynonenal adducted protein in brain, and attenuates synaptic injury in a mouse model of synucleinopathy Xiang Bai, Margaret Wey, Elizabeth Fernández, Matthew J. Hart, Jonathan Gelfond, Alex Bokov, Sheela Rani, Randy Strong
Հրապարակվել է 2015Artigo -
14
-
15
-
16
-
17
Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease Patricia Spilman, Natalia Podlutskaya, Matthew J. Hart, Jayanta Debnath, Olivia Gorostiza, Dale E. Bredesen, Arlan Richardson, Randy Strong, Verónica Galván
Հրապարակվել է 2010Artigo -
18
Lifelong rapamycin administration ameliorates age‐dependent cognitive deficits by reducing IL‐1β and enhancing NMDA signaling Smita Majumder, Antonella Caccamo, David X. Medina, Adriana D. Benavides, Martin A. Javors, Ellen Kraig, Randy Strong, Arlan Richardson, Salvatore Oddo
Հրապարակվել է 2011Artigo -
19
-
20
Որոնման գործիքներ:
Առնչվող խորագիր
Biology
Medicine
Internal medicine
Endocrinology
Biochemistry
Genetics
Physiology
Longevity
Pharmacology
Neuroscience
Disease
Cell biology
Gerontology
PI3K/AKT/mTOR pathway
Chemistry
Signal transduction
Apoptosis
Diabetes mellitus
Dopamine
Enzyme
Parkinson's disease
Acarbose
Gene
Neurodegeneration
Psychology
Sirolimus
Dopaminergic
Life span
Mechanistic target of rapamycin
Ageing